Estrogen Receptor Positive

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2020-05-07
Clinical Trial Update: Taselisib and Enzalutamide in Treating Patients With Androgen Receptor Positive Triple-Negative Metastatic Breast Cancer [Phase 1, Phase 2]
Clinical trial update for taselisib plus enzalutamide in androgen receptor positive triple-negative metastatic breast cancer; trial phases 1…